ErrataErratum

Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

Xingsheng Hu, Dongyong Yang, Yalun Li, Li Li, Yan Wang, Peng Chen, Song Xu, Xingxiang Pu, Wei Zhu, Pengbo Deng, Junyi Ye, Hanhan Zhang, Analyn Lizaso, Hao Liu, Xinru Mao, Hai Huang, Qian Chu and Chengping Hu
Cancer Biology & Medicine May 2020, 17 (2) 513; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0029

In the published article1, the affiliation for the first author, Xingsheng Hu, is “Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences”, we would like to update it to “Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China”. We apologize for the errors and for any confusion it may have caused.

  • Received February 3, 2020.
  • Accepted February 4, 2020.
https://creativecommons.org/licenses/by/4.0/

This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

References

  1. 1.↵
    2. Hu X,
    3. Yang D,
    4. Li Y,
    5. Li L,
    6. Wang Y,
    7. Chen P, et al.
    Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients. Cancer Biol Med. 2019; 16: 556–64.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section